Jeffrey GP - Search Results

1

Predicting liver-related events in NAFLD: A predictive model.

Calzadilla-Bertot L, Jeffrey GP, Wang Z, Huang Y, Garas G, Wallace M, de Boer B, George J, Eslam M, Phu A, Ampuero J, Lucena Valera A, Romero-Gómez M, Aller de la Fuente R, Adams LA. Calzadilla-Bertot L, et al. Among authors: jeffrey gp. Hepatology. 2023 Oct 1;78(4):1240-1251. doi: 10.1097/HEP.0000000000000356. Epub 2023 Mar 31. Hepatology. 2023. PMID: 36994693

2

Ticlopidine-associated cholestatic hepatitis.

Adams L, Jeffrey GP, Deboer B, Garas G. Adams L, et al. Among authors: jeffrey gp. Intern Med J. 2002 Jul;32(7):359-60. doi: 10.1046/j.1445-5994.2002.00241.x. Intern Med J. 2002. PMID: 12088359 No abstract available.

3

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients.

Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, MacQuillan G, Speers D, Jeffrey G. Rossi E, et al. Clin Chem. 2003 Mar;49(3):450-4. doi: 10.1373/49.3.450. Clin Chem. 2003. PMID: 12600957

4

Outcome, tolerability and compliance of compassionate use interferon and ribavirin for hepatitis C infection in a shared care hospital clinic.

Kontorinis N, Garas G, Young J, Speers D, Chester BP, MacQuillan GC, De Boer B, Chapman MD, Forster E, Jeffrey GP. Kontorinis N, et al. Among authors: jeffrey gp. Intern Med J. 2003 Nov;33(11):500-4. doi: 10.1046/j.1445-5994.2003.00410.x. Intern Med J. 2003. PMID: 14656252

5

Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?

Macquillan GC, Niu X, Speers D, English S, Garas G, Harnett GB, Reed WD, Allan JE, Jeffrey GP. Macquillan GC, et al. Among authors: jeffrey gp. J Gastroenterol Hepatol. 2004 May;19(5):551-7. doi: 10.1111/j.1440-1746.2003.03319.x. J Gastroenterol Hepatol. 2004. PMID: 15086599

6

Aciclovir or ganciclovir universal prophylaxis of cytomegalovirus infection in liver transplantation: an economic analysis.

Leong RW, Smith DW, Garas G, Beaman JM, Mitchell AW, Heath DI, House AK, Jeffrey GP. Leong RW, et al. Among authors: jeffrey gp. Intern Med J. 2004 Jul;34(7):410-5. doi: 10.1111/j.1445-5994.2004.00567.x. Intern Med J. 2004. PMID: 15271175

7

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP. Adams LA, et al. Among authors: jeffrey gp. Clin Chem. 2005 Oct;51(10):1867-73. doi: 10.1373/clinchem.2005.048389. Epub 2005 Jul 28. Clin Chem. 2005. PMID: 16055434

8

Epstein-Barr virus-associated cholangiopathy: a new disease entity?

Raftopoulos SC, Garas G, Price R, de Boer WB, Jeffrey GP, Yusoff IF. Raftopoulos SC, et al. Among authors: jeffrey gp. Gastrointest Endosc. 2006 Jan;63(1):172-6. doi: 10.1016/j.gie.2005.07.011. Gastrointest Endosc. 2006. PMID: 16377344 No abstract available.

9

Ganciclovir and the treatment of Epstein-Barr virus hepatitis.

Adams LA, Deboer B, Jeffrey G, Marley R, Garas G. Adams LA, et al. J Gastroenterol Hepatol. 2006 Nov;21(11):1758-60. doi: 10.1111/j.1440-1746.2006.03257.x. J Gastroenterol Hepatol. 2006. PMID: 16984606

10

Assessing liver fibrosis with serum marker models.

Rossi E, Adams LA, Bulsara M, Jeffrey GP. Rossi E, et al. Among authors: jeffrey gp. Clin Biochem Rev. 2007 Feb;28(1):3-10. Clin Biochem Rev. 2007. PMID: 17603636 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page